Literature DB >> 16940113

Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies.

Guan-Qing Wang1, Tatsuo Suzutani, Yumiko Yamamoto, Yoshiko Fukui, Naoki Nozawa, D Scott Schmid, Ichiro Kurane, Naoki Inoue.   

Abstract

To simplify the titration of infectious varicella-zoster virus (VZV), we generated a reporter cell line that produced luciferase in a dose-dependent manner upon infection with cell-free VZV. A few VZV-infected cells were detectable by coculturing with the cell line. We demonstrated the usefulness of the cell line for antiviral studies.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16940113      PMCID： PMC1563536          DOI： 10.1128/AAC.00342-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  33 in total

1.  Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents.

Authors:  R Snoeck; D Schols; C Sadzot-Delvaux; J M Cloes; G Andrei; E De Clercq; J Piette; B Rentier
Journal:  J Virol Methods       Date:  1992-08       Impact factor: 2.014

2.  Transcriptomal analysis of varicella-zoster virus infection using long oligonucleotide-based microarrays.

Authors:  Peter G E Kennedy; Esther Grinfeld; Marie Craigon; Klemens Vierlinger; Douglas Roy; Thorsten Forster; Peter Ghazal
Journal:  J Gen Virol       Date:  2005-10       Impact factor: 3.891

3.  Characterization of a varicella-zoster virus variant with altered thymidine kinase activity.

Authors:  S Shigeta; S Mori; T Yokota; K Konno; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

4.  Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.

Authors:  Naoki Inoue; Thomas Spira; Lee Lam; Jose L Corchero; Wei Luo
Journal:  J Med Virol       Date:  2004-10       Impact factor: 2.327

5.  Array analysis of viral gene transcription during lytic infection of cells in tissue culture with Varicella-Zoster virus.

Authors:  Randall J Cohrs; Michael P Hurley; Donald H Gilden
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 6.  Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.

Authors:  Christian Gilbert; Julie Bestman-Smith; Guy Boivin
Journal:  Drug Resist Updat       Date:  2002-04       Impact factor: 18.500

7.  Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus.

Authors:  K Shiraki; H Ochiai; J Namazue; T Okuno; S Ogino; K Hayashi; K Yamanishi; M Takahashi
Journal:  Antiviral Res       Date:  1992-06       Impact factor: 5.970

8.  Single amino acid change in DNA polymerase is associated with foscarnet resistance in a varicella-zoster virus strain recovered from a patient with AIDS.

Authors:  B Visse; B Dumont; J M Huraux; A M Fillet
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

9.  Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line.

Authors:  Naoki Inoue; Jörn Winter; Renu B Lal; Margaret K Offermann; Shin Koyano
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus.

Authors:  S Shigeta; T Yokota; T Iwabuchi; M Baba; K Konno; M Ogata; E De Clercq
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226
View more
  7 in total

1.  The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo.

Authors:  Xibing Che; Barbara Berarducci; Marvin Sommer; William T Ruyechan; Ann M Arvin
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

2.  Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein.

Authors:  Naoki Inoue; Misato Matsushita; Yoshiko Fukui; Souichi Yamada; Mihoko Tsuda; Chizuka Higashi; Keiko Kaneko; Hideki Hasegawa; Toyofumi Yamaguchi
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

3.  Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay.

Authors:  Yoshiko Fukui; Keiko Shindoh; Yumiko Yamamoto; Shin Koyano; Isao Kosugi; Toyofumi Yamaguchi; Ichiro Kurane; Naoki Inoue
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

4.  A Luciferase Gene Driven by an Alphaherpesviral Promoter Also Responds to Immediate Early Antigens of the Betaherpesvirus HCMV, Allowing Comparative Analyses of Different Human Herpesviruses in One Reporter Cell Line.

Authors:  Anna Katharina Maier; Raimund Jung; Clarissa Villinger; Axel Schubert; Paul Walther; Christian Sinzger; Diana Lieber
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

5.  Characterization of phenyl pyrimidine derivatives that inhibit cytomegalovirus immediate-early gene expression.

Authors:  Koh-Hei Yamada; Ryuichi Majima; Toyofumi Yamaguchi; Naoki Inoue
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

6.  MxB is an interferon-induced restriction factor of human herpesviruses.

Authors:  Michel Crameri; Michael Bauer; Nicole Caduff; Raphael Walker; Fiona Steiner; Francesca D Franzoso; Cornelia Gujer; Karin Boucke; Talissa Kucera; Andrea Zbinden; Christian Münz; Cornel Fraefel; Urs F Greber; Jovan Pavlovic
Journal:  Nat Commun       Date:  2018-05-17       Impact factor: 14.919

Review 7.  Cell Cultures for Virology: Usability, Advantages, and Prospects.

Authors:  Alexander A Dolskiy; Irina V Grishchenko; Dmitry V Yudkin
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.